视网膜再生中的干细胞：过去、现在和未来。
Stem cells in retinal regeneration: past, present and future.
机构信息
The London Project to Cure Blindness, Division of ORBIT, Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK.
出版信息
Development. 2013 Jun;140(12):2576-85. doi: 10.1242/dev.092270.
Abstract
Stem cell therapy for retinal disease is under way, and several clinical trials are currently recruiting. These trials use human embryonic, foetal and umbilical cord tissue-derived stem cells and bone marrow-derived stem cells to treat visual disorders such as age-related macular degeneration, Stargardt's disease and retinitis pigmentosa. Over a decade of analysing the developmental cues involved in retinal generation and stem cell biology, coupled with extensive surgical research, have yielded differing cellular approaches to tackle these retinopathies. Here, we review these various stem cell-based approaches for treating retinal diseases and discuss future directions and challenges for the field.
摘要
正在进行用于治疗视网膜疾病的干细胞疗法，目前有几项临床试验正在招募患者。这些试验使用人胚胎、胎儿和脐带组织衍生的干细胞以及骨髓衍生的干细胞来治疗年龄相关性黄斑变性、斯塔加特病和色素性视网膜炎等视觉障碍。十多年来，对涉及视网膜发生和干细胞生物学的发育线索的分析，加上广泛的外科研究，产生了不同的细胞方法来治疗这些视网膜病变。在这里，我们综述了这些用于治疗视网膜疾病的基于干细胞的各种方法，并讨论了该领域的未来方向和挑战。
相似文献
1
Stem cells in retinal regeneration: past, present and future.视网膜再生中的干细胞：过去、现在和未来。
Development. 2013 Jun;140(12):2576-85. doi: 10.1242/dev.092270.
2
Stem cells in clinical trials for treatment of retinal degeneration.用于治疗视网膜变性的干细胞临床试验
Expert Opin Biol Ther. 2016;16(1):7-14. doi: 10.1517/14712598.2016.1093110. Epub 2015 Sep 28.
3
Cell-Based Therapy for Degenerative Retinal Disease.基于细胞的退行性视网膜疾病治疗。
Trends Mol Med. 2016 Feb;22(2):115-134. doi: 10.1016/j.molmed.2015.12.007. Epub 2016 Jan 11.
4
Gene and Induced Pluripotent Stem Cell Therapy for Retinal Diseases.基因和诱导多能干细胞治疗视网膜疾病。
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:201-216. doi: 10.1146/annurev-genom-083118-015043. Epub 2019 Apr 24.
5
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.人胚胎干细胞源性视网膜色素上皮细胞治疗年龄相关性黄斑变性和斯塔加特型黄斑营养不良患者：两项开放性、1/2 期研究的随访。
Lancet. 2015 Feb 7;385(9967):509-16. doi: 10.1016/S0140-6736(14)61376-3. Epub 2014 Oct 15.
6
Stemming retinal regeneration with pluripotent stem cells.利用多能干细胞实现视网膜再生。
Prog Retin Eye Res. 2019 Mar;69:38-56. doi: 10.1016/j.preteyeres.2018.11.003. Epub 2018 Nov 9.
7
Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.用于年龄相关性黄斑变性的干细胞治疗：挑战
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD78-AMD82. doi: 10.1167/iovs.18-24426.
8
Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.基于细胞的视网膜疾病疗法：临床试验和直接面向消费者的“细胞疗法”诊所综述。
Stem Cell Res Ther. 2021 Oct 11;12(1):538. doi: 10.1186/s13287-021-02546-9.
9
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.基于间充质干细胞的视网膜退行性疾病治疗：实验模型与临床试验。
Cells. 2021 Mar 7;10(3):588. doi: 10.3390/cells10030588.
10
Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.基于干细胞的视网膜色素上皮疾病治疗：从实验室到临床
Semin Ophthalmol. 2016;31(1-2):25-9. doi: 10.3109/08820538.2015.1115253.
引用本文的文献
1
Head and Neck 3D Bioprinting-A Review on Recent Advancements in Soft Tissue 3D Bioprinting and Medical Applications.头颈部3D生物打印——软组织3D生物打印及医学应用的最新进展综述
J Funct Biomater. 2025 Jun 30;16(7):240. doi: 10.3390/jfb16070240.
2
Stem cell therapy as treatment for Stargardt disease.干细胞疗法作为治疗斯塔加特病的方法。
Ther Adv Ophthalmol. 2025 May 23;17:25158414251320592. doi: 10.1177/25158414251320592. eCollection 2025 Jan-Dec.
3
The ABCs of Stargardt disease: the latest advances in precision medicine.斯塔加特病的基础知识：精准医学的最新进展
Cell Biosci. 2024 Jul 26;14(1):98. doi: 10.1186/s13578-024-01272-y.
4
Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration.迈向基于干细胞/祖细胞的视网膜变性治疗方法
Stem Cell Rev Rep. 2024 Aug;20(6):1459-1479. doi: 10.1007/s12015-024-10740-4. Epub 2024 May 29.
5
Autophagy and Exocytosis of Lipofuscin Into the Basolateral Extracellular Space of Human Retinal Pigment Epithelium From Fetal Development to Adolescence.自噬和脂褐素从胎儿发育到青春期向人视网膜色素上皮细胞基底外侧细胞外空间的外排。
Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):32. doi: 10.1167/iovs.65.4.32.
6
Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis.视网膜退行性疾病的细胞治疗：系统评价与三级荟萃分析
J Transl Med. 2024 Mar 2;22(1):227. doi: 10.1186/s12967-024-05016-x.
7
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.患者来源的类器官在人类癌症中的应用：基础研究和精准医学的平台。
Mol Biomed. 2024 Feb 12;5(1):6. doi: 10.1186/s43556-023-00165-9.
8
Generating Retinas through Guided Pluripotent Stem Cell Differentiation and Direct Somatic Cell Reprogramming.通过诱导多能干细胞分化和直接体细胞重编程生成视网膜。
Curr Stem Cell Res Ther. 2024;19(9):1251-1262. doi: 10.2174/011574888X255496230923164547.
9
Therapeutic Potential of Oral-Derived Mesenchymal Stem Cells in Retinal Repair.口腔来源间充质干细胞在视网膜修复中的治疗潜力。
Stem Cell Rev Rep. 2023 Nov;19(8):2709-2723. doi: 10.1007/s12015-023-10626-x. Epub 2023 Sep 21.
10
Stem Cell Therapy in Stargardt Disease: A Systematic Review.Stargardt病的干细胞治疗：一项系统评价。
J Ophthalmic Vis Res. 2023 Jul 28;18(3):318-327. doi: 10.18502/jovr.v18i3.13780. eCollection 2023 Jul-Sep.
本文引用的文献
1
Development of human embryonic stem cell therapies for age-related macular degeneration.人胚胎干细胞疗法治疗年龄相关性黄斑变性的研究进展。
Trends Neurosci. 2013 Jul;36(7):385-95. doi: 10.1016/j.tins.2013.03.006. Epub 2013 Apr 17.
2
Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis in vitro.缺氧提高了从小鼠胚胎干细胞分化而来的光感受器的产量，并改善了体外视网膜发生模型的构建。
Stem Cells. 2013 May;31(5):966-78. doi: 10.1002/stem.1339.
3
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.对来自同基因诱导多能干细胞的分化细胞缺乏免疫反应。
Cell Stem Cell. 2013 Apr 4;12(4):407-12. doi: 10.1016/j.stem.2013.01.006. Epub 2013 Jan 24.
4
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.诱导多能干细胞或胚胎干细胞分化而来的终末细胞的免疫原性可忽略不计。
Nature. 2013 Feb 7;494(7435):100-4. doi: 10.1038/nature11807. Epub 2013 Jan 9.
5
Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation.人 Müller 胶质细胞具有干细胞特性，在体外分化为视网膜神经节细胞 (RGC) 前体细胞，并在移植后部分恢复体内 RGC 功能。
Stem Cells Transl Med. 2012 Mar;1(3):188-99. doi: 10.5966/sctm.2011-0005. Epub 2012 Mar 7.
6
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy.间充质干细胞分泌囊泡为无细胞疗法提供了新的机遇。
Front Physiol. 2012 Sep 6;3:359. doi: 10.3389/fphys.2012.00359. eCollection 2012.
7
Self-formation of optic cups and storable stratified neural retina from human ESCs.人胚胎干细胞诱导形成的自组织类脑器官。
Cell Stem Cell. 2012 Jun 14;10(6):771-785. doi: 10.1016/j.stem.2012.05.009.
8
Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells.采用自体骨髓间充质干细胞治疗 1 例脑瘫合并后视路损伤。
J Transl Med. 2012 May 18;10:100. doi: 10.1186/1479-5876-10-100.
9
Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations.基于单体型的人多能干细胞银行用于移植：潜力与限制。
Stem Cells Dev. 2012 Sep 1;21(13):2364-73. doi: 10.1089/scd.2012.0088. Epub 2012 Jun 11.
10
Restoration of vision after transplantation of photoreceptors.光感受器移植后的视力恢复。
Nature. 2012 May 3;485(7396):99-103. doi: 10.1038/nature10997.
Zotero 插件